In this section you will find older BSP UK press releases from over the last year.
If you have a particular enquiry about any of these releases then please contact us on the telephone number or e-mail address below:-
Tel: 01635 563198
Scottish Medicines Consortium (SMC) accepts Bayer’s new oral anticoagulant for the prevention of venous thromboembolism (VTE) in adults undergoing elective hip or knee replacement surgery
New drug Xarelto® (rivaroxaban), which has been shown to be significantly more effective than current standard, gets UK licence
Final approval from the European Commission expected within the next few months
... 30mg twice-daily in Preventing Blood Clots After Knee Replacement Surgery
...on treatment of pulmonary arterial hypertension in adults
...available for first line treatment of B-cell chronic lymphocytic leukaemia (CLL) for whom fludarabine chemotherapy is not appropriate
New hope and new treatment for hepatocellular carcinoma, the most common primary liver cancer in the UK
